228 related articles for article (PubMed ID: 24040417)
21. Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors.
Corbin S; Neilly ME; Espinosa R; Davis EM; McKeithan TW; Le Beau MM
Cancer Res; 2002 Jun; 62(12):3477-84. PubMed ID: 12067991
[TBL] [Abstract][Full Text] [Related]
22. Molecular mechanisms underlying oncogenic RET fusion in lung adenocarcinoma.
Mizukami T; Shiraishi K; Shimada Y; Ogiwara H; Tsuta K; Ichikawa H; Sakamoto H; Kato M; Shibata T; Nakano T; Kohno T
J Thorac Oncol; 2014 May; 9(5):622-30. PubMed ID: 24722152
[TBL] [Abstract][Full Text] [Related]
23. DNA structural properties of AF9 are similar to MLL and could act as recombination hot spots resulting in MLL/AF9 translocations and leukemogenesis.
Strissel PL; Strick R; Tomek RJ; Roe BA; Rowley JD; Zeleznik-Le NJ
Hum Mol Genet; 2000 Jul; 9(11):1671-9. PubMed ID: 10861294
[TBL] [Abstract][Full Text] [Related]
24. Chromosomal breakpoint positions suggest a direct role for radiation in inducing illegitimate recombination between the ELE1 and RET genes in radiation-induced thyroid carcinomas.
Nikiforov YE; Koshoffer A; Nikiforova M; Stringer J; Fagin JA
Oncogene; 1999 Nov; 18(46):6330-4. PubMed ID: 10597232
[TBL] [Abstract][Full Text] [Related]
25. Breakpoint clusters: reason or consequence?
Bystritskiy AA; Razin SV
Crit Rev Eukaryot Gene Expr; 2004; 14(1-2):65-77. PubMed ID: 15104528
[TBL] [Abstract][Full Text] [Related]
26. Topoisomerase II- and condensin-dependent breakage of MEC1ATR-sensitive fragile sites occurs independently of spindle tension, anaphase, or cytokinesis.
Hashash N; Johnson AL; Cha RS
PLoS Genet; 2012; 8(10):e1002978. PubMed ID: 23133392
[TBL] [Abstract][Full Text] [Related]
27. Rearrangements of the MLL gene are influenced by DNA secondary structure, potentially mediated by topoisomerase II binding.
Le H; Singh S; Shih SJ; Du N; Schnyder S; Loredo GA; Bien C; Michaelis L; Toor A; Diaz MO; Vaughan AT
Genes Chromosomes Cancer; 2009 Sep; 48(9):806-15. PubMed ID: 19530238
[TBL] [Abstract][Full Text] [Related]
28. The response of eukaryotic topoisomerases to DNA damage.
Kingma PS; Osheroff N
Biochim Biophys Acta; 1998 Oct; 1400(1-3):223-32. PubMed ID: 9748592
[TBL] [Abstract][Full Text] [Related]
29. A novel and unified two-metal mechanism for DNA cleavage by type II and IA topoisomerases.
Schmidt BH; Burgin AB; Deweese JE; Osheroff N; Berger JM
Nature; 2010 Jun; 465(7298):641-4. PubMed ID: 20485342
[TBL] [Abstract][Full Text] [Related]
30. Replication of a common fragile site, FRA3B, occurs late in S phase and is delayed further upon induction: implications for the mechanism of fragile site induction.
Le Beau MM; Rassool FV; Neilly ME; Espinosa R; Glover TW; Smith DI; McKeithan TW
Hum Mol Genet; 1998 Apr; 7(4):755-61. PubMed ID: 9499431
[TBL] [Abstract][Full Text] [Related]
31. Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene.
Zimonjic DB; Druck T; Ohta M; Kastury K; Croce CM; Popescu NC; Huebner K
Cancer Res; 1997 Mar; 57(6):1166-70. PubMed ID: 9067288
[TBL] [Abstract][Full Text] [Related]
32. Functional interactions of DNA topoisomerases with a human replication origin.
Abdurashidova G; Radulescu S; Sandoval O; Zahariev S; Danailov MB; Demidovich A; Santamaria L; Biamonti G; Riva S; Falaschi A
EMBO J; 2007 Feb; 26(4):998-1009. PubMed ID: 17290216
[TBL] [Abstract][Full Text] [Related]
33. An antitumor drug-induced topoisomerase cleavage complex blocks a bacteriophage T4 replication fork in vivo.
Hong G; Kreuzer KN
Mol Cell Biol; 2000 Jan; 20(2):594-603. PubMed ID: 10611238
[TBL] [Abstract][Full Text] [Related]
34. Reciprocal DNA topoisomerase II cleavage events at 5'-TATTA-3' sequences in MLL and AF-9 create homologous single-stranded overhangs that anneal to form der(11) and der(9) genomic breakpoint junctions in treatment-related AML without further processing.
Whitmarsh RJ; Saginario C; Zhuo Y; Hilgenfeld E; Rappaport EF; Megonigal MD; Carroll M; Liu M; Osheroff N; Cheung NK; Slater DJ; Ried T; Knutsen T; Blair IA; Felix CA
Oncogene; 2003 Nov; 22(52):8448-59. PubMed ID: 14627986
[TBL] [Abstract][Full Text] [Related]
35. Archaebacterial reverse gyrase cleavage-site specificity is similar to that of eubacterial DNA topoisomerases I.
Kovalsky OI; Kozyavkin SA; Slesarev AI
Nucleic Acids Res; 1990 May; 18(9):2801-5. PubMed ID: 2160070
[TBL] [Abstract][Full Text] [Related]
36. Molecular analysis of 13 cases of MLL/11q23 secondary acute leukemia and identification of topoisomerase II consensus-binding sequences near the chromosomal breakpoint of a secondary leukemia with the t(4;11).
Domer PH; Head DR; Renganathan N; Raimondi SC; Yang E; Atlas M
Leukemia; 1995 Aug; 9(8):1305-12. PubMed ID: 7643617
[TBL] [Abstract][Full Text] [Related]
37. An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site colocalize near exon 9 in the MLL breakpoint cluster region.
Strissel PL; Strick R; Rowley JD; Zeleznik-Le NJ
Blood; 1998 Nov; 92(10):3793-803. PubMed ID: 9808573
[TBL] [Abstract][Full Text] [Related]
38. Topoisomerases as anticancer targets.
Delgado JL; Hsieh CM; Chan NL; Hiasa H
Biochem J; 2018 Jan; 475(2):373-398. PubMed ID: 29363591
[TBL] [Abstract][Full Text] [Related]
39. Interaction in vitro of type III intermediate filament proteins with supercoiled plasmid DNA and modulation of eukaryotic DNA topoisomerase I and II activities.
Li G; Tolstonog GV; Sabasch M; Traub P
DNA Cell Biol; 2002 Oct; 21(10):743-69. PubMed ID: 12443544
[TBL] [Abstract][Full Text] [Related]
40. FRA18C: a new aphidicolin-inducible fragile site on chromosome 18q22, possibly associated with in vivo chromosome breakage.
Debacker K; Winnepenninckx B; Ben-Porat N; FitzPatrick D; Van Luijk R; Scheers S; Kerem B; Frank Kooy R
J Med Genet; 2007 May; 44(5):347-52. PubMed ID: 17475918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
